Heerma Peter
SEC CIK 1789617 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | EVP, Chief COMMERCIAL Off | 125.3K | — | $19.71M | 36 | 2021-08-13 | 2026-09-15 |
Transactions 36
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-17 21:35 | 2026-09-15+ | TVTX | Travere Therapeutics, Inc. | Heerma Peter | EVP, Chief COMMERCIAL Off | M - OptEx | $15.69 | +258.2K | 125.3K | New | +$4.05M |
| DMT | 2026-09-17 21:35 | 2026-09-15+ | TVTX | Travere Therapeutics, Inc. | Heerma Peter | EVP, Chief COMMERCIAL Off | S - Sale+OE | $63.06 | -283.2K | 117.1K | -71% | -$17.86M |
| D | 2026-05-06 20:00 | 2026-05-04 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | M - OptEx | $0.00 | +4,250 | 142.9K | +3% | $0 |
| D | 2026-05-06 20:00 | 2026-05-05 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | S - Sale+OE | $46.65 | -2,174 | 140.7K | -2% | -$101.4K |
| 2026-04-15 21:49 | 2026-04-13 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | A - Grant | $0.00 | +14.0K | 145.8K | +11% | $0 | |
| 2026-04-15 21:49 | 2026-04-14 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $41.93 | -7,215 | 138.6K | -5% | -$302.5K | |
| D | 2026-02-03 | 2026-02-03 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $32.12 | -7,310 | 131.8K | -5% | -$234.8K |
| D | 2026-02-03 | 2026-01-31 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | A - Grant | $0.00 | +26.1K | 139.1K | +23% | $0 |
| 2025-12-29 | 2025-12-24 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $40.00 | -4,980 | 113.0K | -4% | -$199.2K | |
| 2025-11-04 | 2025-10-31 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $35.00 | -5,591 | 119.1K | -4% | -$195.7K | |
| 2025-11-04 | 2025-11-03 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | G - Gift | $0.00 | -1,078 | 118.0K | -0.9% | $0 | |
| 2025-10-30 | 2025-10-28 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $30.00 | -2,662 | 124.7K | -2% | -$79.9K | |
| 2025-09-24 | 2025-09-23 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | G - Gift | $0.00 | -891 | 127.3K | -0.7% | $0 | |
| D | 2025-05-05 | 2025-05-02 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | M - OptEx | — | +4,920 | 130.0K | +4% | — |
| D | 2025-05-05 | 2025-05-05 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | S - Sale+OE | $21.05 | -1,771 | 128.2K | -1% | -$37.3K |
| D | 2025-02-12 | 2025-02-10 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | M - OptEx | — | +8,000 | 130.7K | +7% | — |
| DM | 2025-02-12 | 2025-02-11+ | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | S - Sale+OE | $24.33 | -5,642 | 127.6K | -4% | -$137.3K |
| D | 2025-02-04 | 2025-02-03 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $20.12 | -5,166 | 122.7K | -4% | -$103.9K |
| D | 2025-02-04 | 2025-01-31 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | A - Grant | $0.00 | +21.5K | 127.9K | +20% | $0 |
| 2025-01-23 | 2025-01-22 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $18.94 | -1,584 | 106.4K | -1% | -$30.0K | |
| 2024-09-09 | 2024-09-05 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | A - Grant | $0.00 | +6,750 | 110.1K | +7% | $0 | |
| 2024-09-09 | 2024-09-09 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $11.52 | -2,191 | 108.0K | -2% | -$25.2K | |
| D | 2024-02-02 | 2024-01-31 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | A - Grant | $0.00 | +25.0K | 103.7K | +32% | $0 |
| D | 2024-02-02 | 2024-02-01 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $8.53 | -4,195 | 99.5K | -4% | -$35.8K |
| 2024-01-25 | 2024-01-23 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $9.07 | -1,559 | 78.7K | -2% | -$14.1K | |
| 2023-10-04 | 2023-10-03 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Off | S - Sale | $8.25 | -3,091 | 80.3K | -4% | -$25.5K | |
| D | 2023-02-02 | 2023-01-31 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Off | A - Grant | $0.00 | +20.2K | 83.8K | +32% | $0 |
| D | 2023-02-02 | 2023-02-01 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Off | S - Sale | $21.75 | -1,779 | 82.1K | -2% | -$38.7K |
| 2023-01-26 | 2023-01-24 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Off | S - Sale | $21.90 | -1,550 | 63.6K | -2% | -$33.9K | |
| 2022-10-06 | 2022-10-04 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Off | S - Sale | $25.68 | -3,042 | 65.1K | -4% | -$78.1K | |
| D | 2022-02-02 | 2022-01-31 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Off | A - Grant | $0.00 | +9,840 | 68.4K | +17% | $0 |
| D | 2022-02-02 | 2022-01-31 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Off | S - Sale | $27.40 | -1,125 | 67.3K | -2% | -$30.8K |
| 2022-01-26 | 2022-01-24 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Off | S - Sale | $24.98 | -1,875 | 58.6K | -3% | -$46.8K | |
| 2021-10-05 | 2021-10-04 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Off | S - Sale | $24.77 | -3,058 | 60.5K | -5% | -$75.7K | |
| 2021-08-17 | 2021-08-13 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Off | A - Grant | $0.00 | +4,500 | 64.9K | +7% | $0 | |
| 2021-08-17 | 2021-08-17 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Off | S - Sale | $17.12 | -1,407 | 63.5K | -2% | -$24.1K |